(Q62025856)
Statements
ASPIRE: DETERIMINING THE IMPACT OF CRISABOROLE (Eucrisa) AND TACROLIMUS 0.03% ON PATIENT-REPORTED OUTCOMES AND CAREGIVER BURDEN IN CHILDREN WITH ATOPIC DERMATITIS (English)
0 references
4 February 2019
0 references
30 June 2020
0 references
160
0 references
5 year
0 references
12 year
0 references